Quanta
is an Ohio-based biotechnology company that develops and commercializes dPEG-based products for drug discovery and diagnostic development programs... Read moreQuanta
is an Ohio-based biotechnology company that develops and commercializes dPEG-based products for drug discovery and diagnostic development programs... Read more
News
Jul 25, 2023
FinSMEs
Quanta: Vector Laboratories Acquires Quanta BioDesign
Jul 24, 2023
Acrofan
Quanta: Thompson Street Capital Partner's Vector Laboratories Acquires Quanta BioDesign
May 19, 2022
Quanta Blog
Quanta Blog The Critical Importance of Linker Chemistry for Antibody-Drug Conjugates (ADCs)
May 26, 2021
Quanta Blog
Quanta Blog Marvelous Maleimide Crosslinker Products
Jul 20, 2020
Quanta Blog
Quanta Blog Aminooxy-dPEG11-azide: A New Click Chemistry Crosslinker
Jun 18, 2020
Quanta Blog
Quanta Blog Three Click Chemistry Crosslinking Ideas with dPEG
Jun 11, 2020
Quanta Blog
Quanta Blog Copper-free Click Chemistry to Crosslink Azides and Amines
Oct 26, 2016
Quanta Blog
Quanta Blog Extracellular Drug Conjugates Therapeutically Exploit Protein Proximity
Mar 29, 2016
Quanta Blog
Quanta Blog Amphotericin B+dPEG: Water-Soluble, Less Toxic, Potent
Sep 30, 2015
Quanta Blog
Quanta Blog SNARE-Mediated Membrane Fusion and dPEG, Part 3
